Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Öberg

Showing results (671-680 of 683) with videos related to

Pageof 69
Sort By:
ERJ Open Research|May 25, 2023
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPDVentzislava A Hristova, Alastair Watson, Raghothama Chaerkady, et al.
The New England Journal of Medicine|January 12, 2017
Phase 3 Trial of <sup>177</sup>Lu-Dotatate for Midgut Neuroendocrine TumorsJonathan Strosberg, Ghassan El-Haddad, Edward Wolin, et al.
Journal of Internal Medicine|November 17, 2022
The complexity of kidney disease and diagnosing it - cystatin C, selective glomerular hypofiltration syndromes and proteome regulationLinnea Malmgren, Carl Öberg, Emil den Bakker, et al.
Science (New York, N.Y.)|February 17, 2022
From cohorts to molecules: Adverse impacts of endocrine disrupting mixturesNicolò Caporale, Michelle Leemans, Lina Birgersson, et al.
Environmental Science & Technology|November 9, 2023
Conflicts of Interest in the Assessment of Chemicals, Waste, and PollutionAndreas Schäffer, Ksenia J Groh, Gabriel Sigmund, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2018
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammationZala Jevnikar, Jörgen Östling, Elisabeth Ax, et al.
Molecular Metabolism|January 9, 2018
The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidatesVioleta Georgieva Tsonkova, Fredrik Wolfhagen Sand, Xenia Asbæk Wolf, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 2025
Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome - a new kidney disorder defining selective glomerular hypofiltration syndromes - calls for expansion of the international KDIGO guidelinesAnna Åkesson, Carl Öberg, Linnea Malmgren, et al.
The Lancet. Rheumatology|March 25, 2026
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trialJon Lampa, Dan Nordström, Ronald van Vollenhoven, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2020
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with <sup>177</sup>Lu-Dotatate: an analysis of the NETTER-1 studyJonathan Strosberg, Pamela L Kunz, Andrew Hendifar, et al.
Pageof 69

Showing results (671-680 of 683) with videos related to

Sort By:
Pageof 69
ERJ Open Research|May 25, 2023
Multiomics links global surfactant dysregulation with airflow obstruction and emphysema in COPDVentzislava A Hristova, Alastair Watson, Raghothama Chaerkady, et al.
The New England Journal of Medicine|January 12, 2017
Phase 3 Trial of <sup>177</sup>Lu-Dotatate for Midgut Neuroendocrine TumorsJonathan Strosberg, Ghassan El-Haddad, Edward Wolin, et al.
Journal of Internal Medicine|November 17, 2022
The complexity of kidney disease and diagnosing it - cystatin C, selective glomerular hypofiltration syndromes and proteome regulationLinnea Malmgren, Carl Öberg, Emil den Bakker, et al.
Science (New York, N.Y.)|February 17, 2022
From cohorts to molecules: Adverse impacts of endocrine disrupting mixturesNicolò Caporale, Michelle Leemans, Lina Birgersson, et al.
Environmental Science & Technology|November 9, 2023
Conflicts of Interest in the Assessment of Chemicals, Waste, and PollutionAndreas Schäffer, Ksenia J Groh, Gabriel Sigmund, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2018
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammationZala Jevnikar, Jörgen Östling, Elisabeth Ax, et al.
Molecular Metabolism|January 9, 2018
The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidatesVioleta Georgieva Tsonkova, Fredrik Wolfhagen Sand, Xenia Asbæk Wolf, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 1, 2025
Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome - a new kidney disorder defining selective glomerular hypofiltration syndromes - calls for expansion of the international KDIGO guidelinesAnna Åkesson, Carl Öberg, Linnea Malmgren, et al.
The Lancet. Rheumatology|March 25, 2026
Certolizumab pegol, abatacept, tocilizumab or active conventional therapy in early rheumatoid arthritis: 48-week patient-reported outcomes from the NORD-STAR trialJon Lampa, Dan Nordström, Ronald van Vollenhoven, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2020
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with <sup>177</sup>Lu-Dotatate: an analysis of the NETTER-1 studyJonathan Strosberg, Pamela L Kunz, Andrew Hendifar, et al.
Pageof 69